Cell Biotech Signs Trust Agreement for Treasury Stock Acquisition Worth 5 Billion KRW
[Asia Economy Reporter Lee Jung-yoon] Cell Biotech announced on the 18th that it has signed a trust contract with Hana Financial Investment to acquire its own shares worth 5 billion KRW.
Hot Picks Today
"Could I Also Receive 370 Billion Won?"... No Limit on 'Stock Manipulation Whistleblower Rewards' Starting the 26th
- Samsung Electronics Labor-Management Reach Agreement, General Strike Postponed... "Deficit-Business Unit Allocation Deferred for One Year"
- "From a 70 Million Won Loss to a 350 Million Won Profit with Samsung and SK hynix"... 'Stock Jackpot' Grandfather Gains Attention
- "Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
The company stated that the purpose is to stabilize the stock price and enhance shareholder value, and the contract period is from the 19th of this month to August 18th.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
